Remifentanil hydrochloride

Remifentanil hydrochloride is a potent, ultra-short-acting synthetic opioid analgesic drug. It is a specific agonist at the μ-opioid receptor, with its primary clinical use being as an anesthesia adjunct in the induction and maintenance of general anesthesia, often in combination with other agents. Remifentanil has the unique property of rapid onset and quick recovery time compared to other opioids, making it ideal for short surgical procedures and in the intensive care unit for short-term sedation.

Chemical and Physical Properties

Remifentanil hydrochloride is the hydrochloride salt form of remifentanil. It is chemically designated as 3-[(4-methoxycarbonyl-4-[(1-oxopropyl)phenylamino]-1-piperidine)propyl] phenyl ester hydrochloride. The drug is presented as a sterile, nonpyrogenic, lyophilized powder for intravenous (IV) injection after reconstitution with an appropriate diluent.

Pharmacology

Remifentanil's pharmacological effects are primarily due to its action as an agonist at the μ-opioid receptor. Its analgesic and sedative effects are dose-dependent. The drug has a rapid onset of action, typically within 1-2 minutes after IV administration, and a short duration of action, with its effects diminishing rapidly after discontinuation due to its rapid metabolism by nonspecific blood and tissue esterases. This metabolism is unique among opioids, as it does not rely on renal or hepatic pathways, making remifentanil a safer choice in patients with compromised liver or kidney function.

Clinical Uses

Remifentanil hydrochloride is used primarily in the operating room setting for the induction and maintenance of general anesthesia, often in combination with other anesthetic agents. Its rapid onset and short duration of action allow for precise control of the depth of anesthesia. It is also used for providing analgesia during mechanically ventilated patients in the intensive care unit and for procedural sedation for short, painful procedures outside the operating room.

Side Effects

As with other opioids, the use of remifentanil can be associated with side effects, including but not limited to, respiratory depression, bradycardia, hypotension, and muscle rigidity. Due to its potent opioid activity, there is also a risk of misuse, abuse, and addiction. Naloxone can reverse the effects of remifentanil in cases of overdose.

Contraindications

Remifentanil should be used with caution in patients with known hypersensitivity to the drug or other fentanyl analogs. It should also be used with caution in patients with compromised respiratory function or with a history of substance abuse.

Conclusion

Remifentanil hydrochloride represents a significant advancement in the field of anesthesia, providing anesthesiologists with a powerful tool for managing pain and sedation with a favorable safety profile, especially in patients with compromised organ function. Its unique pharmacokinetic properties allow for rapid adjustment of anesthesia depth and quick patient recovery, making it an invaluable agent in modern anesthetic practice.

‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian